RxDoctor Payments Data

Gregory Michaud, MD

Clinical Cardiac Electrophysiology · Boston, MANPI 1386606705

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 42.1% of the total. Among clinical cardiac electrophysiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$244,025in general payments, 2019–2025

Across 455 payments — averaging $536.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$103K
  • Biosense Webster, Inc.$35K
  • Biotronik Inc.$29K
  • Medical Device Business Services, Inc.$27K
  • Medtronic$26K
  • Boston Scientific$22K
  • plus $2K from 6 others
$26,392in research payments, 2019–2025

Across 8 payments — averaging $3299.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$16K
  • Medtronic$10K
  • Abbott$100

What the payments were for

  • Consulting fees$90,05137%
  • Speaking & faculty fees$110,18545%
  • Travel & lodging$24,25410%
  • Food & beverage$19,5228%
  • Education$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$244,025 in reported general payments places this provider in the 90th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$168,757
Medicare patients
731
Services billed
1,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban42$42,521

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →